Structure-Activity Relationships Among 9-N-Alkyl Derivatives of Erythromycylamine and Their Effect on the Oxidative Burst of Human Neutrophils In Vitro

References

• Chu DTW. Progress in macrolide and ketolide antibacte-rials. Annu Rep Med Chem 2000; 35: 145–155.
   Web of Science ®Google Scholar
• Kaneko T, McArthur H, Sutcliffe J. Recent develop-ments in the area of macrolide antibiotics. Exp Opin Ther Patents 2000; 10: 403–425.
   Web of Science ®Google Scholar
• Bryskier A. New research in macrolides and ketolides since 1997. Exp Opin Invest Drugs 1999; 8: 1171-1194.
   Google Scholar
• Bryskier A, Agouridas C, Chantot JF. New medical tar-gets for macrolides. Exp Opin Invest Drugs 1994; 3: 405–410.
   Google Scholar
• Labro MT, Abdelghaffar H. Immunomodulation by macrolide antibiotics. J Chemother 2001; 13: 3–8.
   PubMed Web of Science ®Google Scholar
• Labro MT. Effects of macrolides on host natural defences. In: AJ Bryskier, JP Butzler, HC Neu, PM Tulkens eds. Macrolides: chemistry, pharmacology and clinical uses. Paris: Arnette Blackwell, 1993: 389–408.
   Google Scholar
• Labro MT. Immunological effects of macrolides. Curr Opin Infect Dis 1998; 11: 681–688.
   PubMed Web of Science ®Google Scholar
• Labro MT. Effects of macrolides on leukocytes and inflammation. In: SH Zinner, LS Young, JF Acar, HC Neu, eds. Expanding indications for the new macrolides, azalides and streptogramins. New York: Marcel Dekker Inc., 1997: 101-116.
   Google Scholar
• Labro MT. Anti-inflammatory activity of macrolides: a new therapeutic potential? J Antimicrob Chemother 1998; 41 (suppl. B): 37-46.
   Google Scholar
• Kobayashi H. Airway biofilm disease, its clinical mani-festation and therapeutic possibilities of macrolides. Am J Med 1995; 99 (Suppl. 6A): S26-S30.
   Google Scholar
• Scaglione F, Rossoni G. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin. J Antimicrob Chemother 1998; 41: 47–50.
   PubMedGoogle Scholar
• Babior BM. Oxidants from phagocytes: agents of defense and destruction. Blood 1984; 64: 959–966.
   PubMed Web of Science ®Google Scholar
• Abdelghaffar H, Vazifeh D, Labro MT. Erythromycin A—derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway. J Immunol 1997; 159: 3995–4005.
   PubMed Web of Science ®Google Scholar
• Anderson R, Van Rensburg CEJ, Eftychis H, Joonê G, Van Rensburg AJ. Further studies on erythromycin effects on cellular immune functions in vitro and in vivo. Enhancement of neutrophil motility by erythromycin combined with ascorbate or thiamine. J Antimicrob Chemother 1982; 10: 409–417.
   Google Scholar
• Joonê GK, Van Rensburg CEJ, Anderson R. Investigation of the in-vitro uptake, intraphagocytic biological activity and effects on neutrophil superoxide generation of dirithromycin compared with erythromycin. J Antimicrob Chemother 1992; 30: 509–523.
   PubMed Web of Science ®Google Scholar
• Bryskier A, Agouridas C, Chantot JF. Ketolides: new semi-synthetic 14-membered-ring macrolides. In: SH Zinner, LS Young, JF Acar, HC Neu eds. Expanding indications for the new macrolides, azalides, and streptogramins. New York: Marcel Dekker, Inc., 1997: 39-50.
   Google Scholar
• Vazifeh D, Preira A, Bryskier A, Labro MT. Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils. Antimicrob Agents Chemother 1998; 42: 1944-1951.
   Google Scholar
• Vazifeh D, Bryskier A, Labro MT. Effect of proinflam-matory cytokines on the interplay between roxithromycin, HMR 3647 or HMR 3004 and polymorphonuclear neu-trophils. Antimicrob Agents Chemother 2000; 44: 511–521.
   PubMed Web of Science ®Google Scholar
• Massey EH, Kitchell BS, Martin LD, Gerzon K. Antibacterial activity of 9(S)-erythromycylamine-aldehyde con-densation products. J Med Chem 1974; 17: 105–107.
   PubMed Web of Science ®Google Scholar
• Labro MT, El Senna J, Abdelghaffar H. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. J Antimicrob Chemother 1993; 31 (Suppl. C): 51-64.
   Google Scholar
• Ryden R, Timms GH, Prime DM, Wildsmith E. N-sub-stituted derivatives of erythromycylamine. J Med Chem 1973; 16: 1059–1060.
   PubMed Web of Science ®Google Scholar
• Kirst HA, Wind JA, Leeds JP, et al. Synthesis and structure-activity relationships of new 9-N-alkyl derivatives of 9(S)-erythromycylamine. J Med Chem 1990; 33: 3086-3094.
   Google Scholar
• Bergmeyer HU, Bernt E. Lactate dehydrogenase. In: Methods in enzymatic analysis, HU Bergmeyer, ed. New York, Academic Press, Inc., 1963: 737-739.
   Google Scholar
• Smith JA. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994; 56: 672–686.
   PubMed Web of Science ®Google Scholar
• Miesel R, Sanocka D, Kurpisz M, Kroger H. Antiinflammatory effects of NADPH oxidase inhibitors. Inflammation 1995; 19: 347–362.
   PubMed Web of Science ®Google Scholar
• Cross AR. Inhibitors of the leukocyte superoxide gener-ating oxidase. Free Radicals Biol Med 1990; 8: 71–93.
   PubMed Web of Science ®Google Scholar
• Labro MT. Interference of antibacterial agents with phagocyte functions: immunomodulation or « immuno-f airy tales. Clin Microbiol Rev 2000; 13: 615–650.
   PubMed Web of Science ®Google Scholar
• Wenisch C, Parschalk B, Zedtwitz-Liebenstein K, Weihs A, El Menyawi I, Graninger W. Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymor-phonuclear leukocyte function assessed ex vivo by flow cytometry. Antimicrob Agents Chemother 1996; 40: 2039–2042.
   PubMed Web of Science ®Google Scholar
• Labro MT, El Senna J, Barre J. Effect of roxithromycin and erythromycin on human neutrophil functions ex vivo. In: Program and abstracts of the first International conference on the macrolides, azalides and streptogramins. January 22-25, 1992, Santa Fe, New Mexico, USA. Abstr. 175.
   Google Scholar
• Duong M, Simard M, Bergeron Y, Ouellet N, Cotê-Richer M, Bergeron MG. Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice. Antimicrob Agents Chemother 1998; 42: 3309–3312.
   PubMed Web of Science ®Google Scholar
• Duong M, Simard M, Bergeron Y, Bergeron MG. Kinetic study of the inflammatory response in Streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004. Antimicrob Agents Chemother 2001; 45: 252–262.
   PubMed Web of Science ®Google Scholar
• Colbert WE, Turk JA, Williams PD, Buening MK. Cardiovascular and autonomic pharmacology of the macrolide antibiotic LY281389 in anesthetized beagles and in isolated smooth and cardiac muscles. Antimicrob Agents Chemother 1991; 35: 1635-1639.
   Google Scholar
• Horn JW, Jensen CB, White SL, et al. In vitro and in vivo ultrastructural changes induced by macrolide antibiotic LY281389. Fundam Appl Toxicol 1996; 32: 205–216.
   PubMedGoogle Scholar